连花清瘟胶囊联合磷酸奥司他韦治疗流行性感冒的临床效果及价值研究

Clinical effect and value of Lianhua Qingwen capsule combined with Oseltamivir Phosphate in the treatment of influenza

目的探究连花清瘟胶囊联合磷酸奥司他韦治疗流行性感冒的临床效果及价值。方法2019年1月-2020年1月,选择天津市东丽区华明社区卫生服务中心收治的流行性感冒患者作为研究样本,随机选择82例,抽签平分为对照组、试验组,分别给予常规治疗、连花清瘟胶囊联合磷酸奧司他韦治疗,比较两组治疗效果,统计症状消失时间及炎性指标、T淋巴细胞亚群情况。结果试验组临床治疗总有效率高于对照组,P<0.05;试验组发热、咳嗽,咽喉肿痛、周身酸痛消失时间短于对照组,p<0.05;两组治疗后C反应蛋白(CRP)、白介素-6(IL-6)均低于同组治疗前,T淋巴细胞亚群(CD^(+)_(4)/CD^(+)_(3)比值)高于同组治疗前,P<0.05,组间对比试验组CRP、IL-6低于对照组,CD^(+)_(4)/CD^(+)_(3)比值高于对照组,p<0.05.结论流行性感冒发病率较高,连花清瘟胶囊联合磷酸奧司他韦治疗后,患者恢复快,效果理想,整体状态改善良好,值得借鉴。

0bjective To explore the clinical effect and value of Lianhua Qingwen capsule combined with Oseltamivir Phosphate in the treatment of infuenza.Methods From January 2019 to January 2020,82 patients were randomly selected and divided into control group and test group.They were given routine treatment,Lianhua Qingwen capsule combined with Oseltamivir Phosphatethe effect of treatment was compared,and the time of symptom disappearance,inflammatory index and T lymphocyte were counted.Results The total effective rate of the test group was higher than that of the control goup(P<0.05)and the disappearance time of fever,cough,sore throat and body ache in the test group was shorter than that in the control group(P<0.05).Creactive protein(CRP)and interleukin-6(L-6)in both groups were lower than those in the same group before treatment,and T lymphoeyte(CD^(+)_(4)/CD^(+)_(3)ratio)were higher than those in the same group before treatment(P<0.05),the ratio of CD^(+)_(4)/CD^(+)_(3)was higher than that of Control Group(P<0.05).Conclusion The incidence of infuenza is high,Lianbua qingwen capsule combined with Oselamivir Phosphate in the treatment of patients recover quickly,the effect is ideal,the overall improvement is good,it is worth learning.